Topiramate: antipsychotic-induced weight gain (Q33774799)

29 July 2017

title

Topiramate: antipsychotic-induced weight gain (English)

1 reference

29 July 2017

1 reference

Joyce A Generali

1

1 reference

29 July 2017

Dennis J Cada

series ordinal

2

1 reference

29 July 2017

publication date

1 April 2014

1 reference

29 July 2017

1 reference

29 July 2017

volume

49

1 reference

29 July 2017

issue

4

1 reference

29 July 2017

page(s)

345-347

1 reference

Effect of topiramate on weight gain in patients receiving atypical antipsychotic agents

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062746

Second-generation antipsychotic use in schizophrenia and associated weight gain: a critical review and meta-analysis of behavioral and pharmacologic treatments.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062746

Systematic Review and Meta-analysis of Pharmacological Interventions for Weight Gain from Antipsychotics and Mood Stabilizers.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062746

Long-term topiramate treatment of psychotropic drug-induced weight gain: a retrospective chart review

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062746

Open-label adjunctive topiramate in the treatment of bipolar disorders.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062746

Weight loss with topiramate

4 July 2018

1 reference

https://api.crossref.org/works/10.1310%2FHPJ4904-345

Long-term effects of topiramate on bipolar mood instability, weight change and glycemic control: a case-series

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHPJ4904-345

Topiramate for prevention of olanzapine associated weight gain and metabolic dysfunction in schizophrenia: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHPJ4904-345

Topiramate add-on treatment in schizophrenia: a randomised, double-blind, placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHPJ4904-345

Influence of topiramate on olanzapine-related weight gain in women: an 18-month follow-up observation

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHPJ4904-345

Effects on weight and outcome of long-term olanzapine-topiramate combination treatment in bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHPJ4904-345

21 January 2018

Identifiers

DOI

10.1310/HPJ4904-345

1 reference

29 July 2017

1 reference

29 July 2017

1 reference